Medical/Pharmaceuticals
SNIPR Biome reports positive clinical interim results for groundbreaking, first-in-human, CRISPR-based microbial gene therapy
* SNIPR001 demonstrates proof of principle in reducing E. coli levels in the human gastrointestinal tract * SNIPR001 is a novel CRISPR-Cas therapeutic, selectively targeting antibiotic-resistant E. coli which can cause life-threatening infections in vulnerable hematological cancer patients ...
2023-05-31 14:58
1985
Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial Agreement
EAST RUTHERFORD, N.J, May 31, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, yesterday celebrated the grand opening of its new Q1 Scientific...
2023-05-31 14:30
2246
AffaMed Therapeutics Announces Completion of Patient Enrollment in the Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Cataract Surgery Patients
SHANGHAI, May 31, 2023 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmological, neurological and psychiat...
2023-05-31 11:39
2216
Lynk Pharmaceuticals Completes 200 Million RMB Series C1 Financing to Accelerate Clinical Development of Core Products
HANGZHOU, China, May 31, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, today announced the successful completion of aRMB 200 million Series C1 financing round. There was joint participation by China G...
2023-05-31 08:25
4003
Excellent 12-Month Results from SELUTION SFA Trial Presented at JET
GENEVA, May 31, 2023 /PRNewswire/ -- 12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference inTokyo. The objective of this study was to assess the safety and efficacy of SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, fo...
2023-05-31 08:00
2508
Brain-computer interface to control digital devices using thoughts: The European Patent Office has announced that Australian researchers have been selected as finalists for the European Inventor Award 2023
MUNICH, May 31, 2023 /PRNewswire/ -- Nearly one in six of the world's population lives with neurological disorders such as Alzheimer's, Parkinson's disease, stroke, epilepsy, or migraines and brain injuries, according to the United Nations. In an effort to improve the quality of life for those af...
2023-05-31 05:00
2284
LZ901, A Recombinant Herpes Zoster Vaccine And The Core Product Of Luzhu Biotechnology, Completed Phase II Clinical Trail In Q2 2023
World's First Herpes Zoster Vaccine With A Tetrameric Molecular Structure BEIJING, May 30, 2023 /PRNewswire/ -- Beijing Luzhu Biotechnology Co., Ltd. ("Luzhu Biotechnology" or the "Company", together with its subsidiaries, the "Group", stock code: 02480.HK), a leading vaccine and antibody drug de...
2023-05-30 22:07
3201
Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand
MUMBAI, India and SIENA, Italy, May 30, 2023 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO), (Bloomberg: SUNP IN), (NSE: SUNPHARMA), (BSE: 524715) (together with its subsidiaries and/or associated companies, "Sun Pharma") and Philogen S.p.A (BIT: PHIL) today announced tha...
2023-05-30 22:05
2528
Fullerton Health Officially Opens its Flagship Health Screening Centre at Novena
This is one of the largest and most comprehensive health screening & preventative health facilities inSingapore SINGAPORE, May 30, 2023 /PRNewswire/ -- Fullerton Health Group's (FHG) newest and largest Health Screening Centre was officially launched by Health Minister Ong Ye Kung at an official o...
2023-05-30 15:00
3120
BMC Corporate Launches New Products and Strategies at Latest Exhibitions
BEIJING, May 30, 2023 /PRNewswire/ -- BMC participated in two comprehensive exhibitions inMay 2023 - CMEF and Hospitalar. At these events, BMC showcased not only its newest products and solutions, but also its business Strategies. Founded in 2001, BMC's mission is to partner with families worldwi...
2023-05-30 12:43
2888
VISTA Eye Specialist Shines At The Natural Health & Readers' Choice Awards 2022
PETALING JAYA, Malaysia, May 30, 2023 /PRNewswire/ -- VISTA Eye Specialist, one of the leading eye specialists inMalaysia with 14 locations throughout the nation has once again emerged victorious at the Natural Health Awards and Readers' Choice Awards 2022 by winning the Best LASIK Eye Surgery Ce...
2023-05-30 10:16
2493
Guardant Health Receives Regulatory Approval from Singapore's Health Sciences Authority for Guardant360® CDx blood test for patients with advanced solid cancers
* Guardant360® CDx is a comprehensive genomic profiling blood test that provides critical information to help inform personalized treatment decisions for patients with advanced solid cancers * The liquid biopsy test is also approved as a companion diagnostic for TAGRISSO® (osimertinib) in ...
2023-05-30 09:00
2922
Haleon's Panadol Klinik Cekatan extends reach to people with limited mobility and healthcare access in areas affected by natural disasters
* The extended program aims provide 10,000 free consultations across 16 villages in Cugenang district affected by 2022 earthquake * The eight-week mobile clinic services program to deploy pilot Pain Phone unit to facilitate telehealth consultation JAKARTA, Indonesia, May 29, 2023 /PRNewswir...
2023-05-29 21:51
4651
Concept Medical's fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)
TAMPA, Fla., May 29, 2023 /PRNewswire/ -- The US FDA, on the 24th of May 2023,
granted an Investigational Device Exemption (IDE) approval forConcept Medical
Inc's
2023-05-29 19:40
3315
Hummingbird Bioscience Announces HMBD-002 Trials in Progress Poster at ASCO Annual Meeting 2023
* HMBD-002, a non-depleting, high-affinity anti-VISTA antibody, possesses key design features enabling robust anti-tumor activity in preclinical models, positioning it as a potentially important new therapy for VISTA-expressing cancers including triple-negative breast cancer and non-small cell ...
2023-05-29 18:30
2921
Kosme Aesthetics Celebrates the Opening of its Modern Aesthetic Salon at Plaza Singapura, Orchard Road, Offering a Comprehensive Range of Signature Treatments
SINGAPORE, May 29, 2023 /PRNewswire/ -- Kosme Aesthetics, a renowned provider of state-of-the-art aesthetic treatments inSingapore, is excited to announce the opening of its new salon at Plaza Singapura, #04-08D, Orchard Road. The contemporary facility showcases the brand's dedication to offering...
2023-05-29 11:10
2073
APPLICATION OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT: EXPERIENCE FROM THE WORLD AND SITUATION IN VIETNAM
HO CHI MINH CITY, Vietnam, May 29, 2023 /PRNewswire/ -- In the limited medical sources circumstance, the technology evaluation will help policymakers choose and establish the most appropriate health technology coordinating with conditions and actual occurrences, thereby ensuring the best medical ...
2023-05-29 11:00
2263
Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023
* ORSERDU (elacestrant) was approved by the FDA in January 2023 for estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer withESR1-mutations (ESR1-mut) that are found in up to 40% of tumors * In patients whose tumors har...
2023-05-26 20:37
2910
Guizhou uses big data tech to develop smart healthcare
GUIYANG, China, May 26, 2023 /PRNewswire/ -- A news report from Huanqiu.com: "It always took me over half a day to take my child to go to the county and see a doctor for a minor illness several years ago. Now we can get remote diagnosis and treatment services from the higher-level hospital when w...
2023-05-26 11:00
3161
Antengene To Present Latest Results from TORCH-2 Study of ATG-008 in Advanced Solid Tumors in Poster Discussion at ASCO 2023
* The TORCH-2 study is a Phase I/II trial of the mTORC1/2 inhibitor ATG-008 plus the Anti-PD-1 monoclonal antibody toripalimab for the treatment of patients with advanced solid tumors * The combination treatment produced an objective response rate (ORR ) of 52.4% in the advanced cervical canc...
2023-05-26 09:41
3079
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
9173
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7712